Korro Bio (KRRO) Total Non-Current Liabilities (2021 - 2026)

Korro Bio's Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $62.5 million for Q1 2026.

• Quarterly Total Non-Current Liabilities rose 1.16% year-over-year to $62.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $62.5 million (up 1.16% YoY) and the FY2025 annual result came in at $60.6 million, down 5.85% from the prior year.
• Total Non-Current Liabilities was $62.5 million for Q1 2026 at Korro Bio, up from $60.6 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $64.4 million in Q4 2024 and bottomed at $8.9 million in Q4 2022.
• A 5-year average of $49.7 million and a median of $53.7 million in 2022 frame the typical range for Total Non-Current Liabilities.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities plunged 83.64% — and 2024, when it soared 557.45%.
• Korro Bio's Total Non-Current Liabilities stood at $8.9 million in 2022, then surged by 469.01% to $50.7 million in 2023, then increased by 26.93% to $64.4 million in 2024, then declined by 5.85% to $60.6 million in 2025, then rose by 3.2% to $62.5 million in 2026.
• Business Quant data shows KRRO's Total Non-Current Liabilities at $62.5 million in Q1 2026, $60.6 million in Q4 2025, and $61.0 million in Q3 2025.